Healx

Healx

UK - Cambridge
Biotechnology
WebsiteLinkedInCareers Page

Focus: AI Drug Discovery

Healx is a life sciences company focused on AI Drug Discovery.

Rare DiseasesNeurology
Funding Stage
PUBLIC
Open Jobs
2

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT03109756Single Dose Pharmacokinetic (PK) Study
Phase 1
Phase 1/2
Phase 2
Clinical Trials (1)
NCT04823052Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40
Phase 2
Phase 2
OV101 Regimen 1
Angelman Syndrome
Phase 2
Clinical Trials (1)
NCT02996305A Study in Adults and Adolescents With Angelman Syndrome (STARS)
Phase 2
Phase 2
Clinical Trials (1)
NCT06334419Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)
Phase 2
Phase 2
Clinical Trials (1)
NCT06541847A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Phase 2
Phase 2
Clinical Trials (1)
NCT03697161A Study of OV101 in Individuals With Fragile X Syndrome
Phase 2
TAK-935
Epilepsy
Phase 2
Phase 3
Clinical Trials (1)
NCT03882918An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
Phase 3
Phase 3
Clinical Trials (1)
NCT04106557A Study of OV101 in Individuals With Angelman Syndrome (AS)
Phase 3

Open Jobs (2)

Platform Engineer

Cambridge
Technology
3w ago

Bioinformatician

Cambridge
Pre-Clinical
2mo ago
Interview Prep Quick Facts
Founded: 2005
Portfolio: 8 clinical trials
Open Roles: 2 active jobs

Hiring Trend

Stable
2
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles